32 Grants (Page 1 of 2)
2015
Methods to enable cholesterol catabolism in human monocyte derived macrophages
Honkanen, Richard E
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL110937-05), $334,125USD, 09/23/2011 -- 06/30/2016
2014
Methods to enable cholesterol catabolism in human monocyte derived macrophages
Honkanen, Richard E
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL110937-04), $334,125USD, 09/23/2011 -- 06/30/2016
2013
Methods to enable cholesterol catabolism in human monocyte derived macrophages
Honkanen, Richard E
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL110937-03), $324,101USD, 09/23/2011 -- 06/30/2016
2012
Methods to enable cholesterol catabolism in human monocyte derived macrophages
Honkanen, Richard E
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL110937-02), $334,125USD, 09/23/2011 -- 06/30/2016
2011
Methods to enable cholesterol catabolism in human monocyte derived macrophages
Honkanen, Richard E
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 1R01HL110937-01), $359,125USD, 09/23/2011 -- 06/30/2016
2010
Development of a HTS-assay for inhibitors of a type 2C protein phosphatase (PPM
Honkanen, Richard E
National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS) (ID: 1R21NS071553-01), $148,333USD, 06/01/2010 -- 05/31/2012
2009
HTP screening for inhibitors of ser/the protein phosphatase 5
Honkanen, Richard E
National Institutes of Health (NIH), National Institute of Mental Health (NIMH) (ID: 1R03MH085702-01A1), $25,000USD, 04/16/2009 -- 04/15/2011
 
Mechanisms of tumor promotion and carcinogenesis
Honkanen, Richard E
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 3R01CA060750-15S1), $25,000USD, 01/01/1994 -- 02/28/2010
2008
Mechanisms of tumor promotion and carcinogenesis
Honkanen, Richard E
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA060750-15), $249,183USD, 01/01/1994 -- 02/28/2010
2007
Mechanisms of tumor promotion and carcinogenesis
Honkanen, Richard E
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA060750-14), $249,183USD, 01/01/1994 -- 02/28/2009
 
Mechanisms of tumor promotion and carcinogenesis
Honkanen, Richard E
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 3R01CA060750-14S1), $53,700USD, 01/01/1994 -- 02/28/2009
2006
Mechanisms of tumor promotion and carcinogenesis
Honkanen, Richard E
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 3R01CA060750-13S1), $52,306USD, 01/01/1994 -- 02/28/2009
 
Mechanisms of tumor promotion and carcinogenesis
Honkanen, Richard E
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA060750-13), $256,624USD, 01/01/1994 -- 02/28/2009
 
Mechanisms of tumor promotion and carcinogenesis
Honkanen, Richard E
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 3R01CA060750-13S2), $15,000USD, 01/01/1994 -- 02/28/2009
2005
Mechanisms of tumor promotion and carcinogenesis
Honkanen, Richard E
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA060750-12), $262,800USD, 01/01/1994 -- 03/31/2009
 
Mechanisms of tumor promotion and carcinogenesis
Honkanen, Richard E
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 3R01CA060750-12S1), $50,953USD, 01/01/1994 -- 03/31/2009
2004
Mechanisms of tumor promotion and carcinogenesis
Honkanen, Richard E
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 2R01CA060750-11), $262,800USD, 01/01/1994 -- 03/31/2009
 
Mechanisms of tumor promotion and carcinogenesis
Honkanen, Richard E
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 3R01CA060750-11S1), $42,339USD, 01/01/1994 -- 03/31/2009
2003
MECHANISMS OF TUMOR PROMOTION AND CARCINOGENESIS
Honkanen, Richard E
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA060750-10), $252,991USD, 01/01/1994 -- 03/31/2004
2002
CARDIOPROTECTIVE AGENTS IN ISCHEMIC MYOCYTES
Honkanen, Richard E
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL059154-04), $218,511USD, 09/01/1999 -- 08/31/2004
 
MECHANISMS OF TUMOR PROMOTION AND CARCINOGENESIS
Honkanen, Richard E
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA060750-09), $245,623USD, 01/01/1994 -- 01/31/2004
2001
CARDIOPROTECTIVE AGENTS IN ISCHEMIC MYOCYTES
Honkanen, Richard E
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL059154-03), $212,146USD, 09/01/1999 -- 08/31/2003
 
MECHANISMS OF TUMOR PROMOTION AND CARCINOGENESIS
Honkanen, Richard E
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA060750-08), $238,467USD, 01/01/1994 -- 01/31/2004
2000
CARDIOPROTECTIVE AGENTS IN ISCHEMIC MYOCYTES
Honkanen, Richard E
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL059154-02), $205,966USD, 09/01/1999 -- 08/31/2003
 
MECHANISMS OF TUMOR PROMOTION AND CARCINOGENESIS
Honkanen, Richard E
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA060750-07), $231,522USD, 01/01/1994 -- 01/31/2004